# The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

> clinical trial · VERIFIED · 2026-07-29

Status: RECRUITING · Sponsor: SetPoint Medical Corporation · Condition: Relapsing Remitting Multiple Sclerosis

- Company: SetPoint Medical Corporation
- Sector: medical devices
- Primary source: https://clinicaltrials.gov/study/NCT06796504

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.